Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
53.29
+0.22 (0.41%)
At close: Nov 6, 2026, 4:00 PM EST
52.49
-0.80 (-1.50%)
After-hours: Nov 6, 2026, 7:30 PM EST
Pulse Biosciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Pulse Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $66.67. The average 1-year stock price forecast is 25.11% higher than the current stock price, while the lowest is $58 (+8.84%) and the highest is $74 (+38.86%).
Price Target: $66.67 (+25.11%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pulse Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 5 | 5 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 4 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $70 | Buy | Reiterates | $70 | +31.36% | Nov 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $58 → $74 | Buy | Maintains | $58 → $74 | +38.86% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $55 → $65 | Buy | Maintains | $55 → $65 | +21.97% | Nov 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $60 | Buy | Maintains | $35 → $60 | +12.59% | Oct 13, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Initiates $73 | Buy | Initiates | $73 | +36.99% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
2.03M
from 350.00K
Increased by 480.71%
Revenue Next Year
5.65M
from 2.03M
Increased by 177.98%
EPS This Year
-1.11
from -0.75
EPS Next Year
-1.17
from -1.11
EPS and Forward PE are based on non-GAAP adjusted numbers.